Tout sur Linos Vandekerckhove

Passer d'une trithérapie classique vers un 2DR (DTG/3TC) a-t-il un impact sur l'ADN total ou l'ADN proviral intact des réservoirs viraux et, plus généralement, sur la dynamique des réservoirs? Telle est la question à laquelle le Pr Linos Vandekerckhove (UZ Gent) a tenté de répondre lors de la présentation des premiers résultats de l'étude Rumba à Glasgow.

Partner content ViiV Healthcare

Lire l'article

Live from

Lire les articles

Online e-learning

Real-world treatment adherence and strict inclusion criteria used during RCTs can lead to several patient groups being underrepresented. Therefore, real-world data on DTG-based 2DRs are highly needed to be able to evaluate virologic and safety outcomes in these underrepresented patient groups.In this webinar, Dr. Nasreddine highlighted the outcomes of the BREACH DTG-based 2DR cohort, a retrospective, observational, multicenter study (n=10).Subsequently Prof. De Wit, Chair of the Belgian HIV Research Consortium BREACH, gave his clinical implications of these cohort data.Finally, Dr. De Scheerder provided a comprehensive overview of the real-world DTG/3TC data that are currently available beyond Belgium.

Take the course